Seguir
Laurent Poirel
Laurent Poirel
University of Fribourg
Dirección de correo verificada de unifr.ch
Título
Citado por
Citado por
Año
Global spread of carbapenemase-producing Enterobacteriaceae
P Nordmann, T Naas, L Poirel
Emerging infectious diseases 17 (10), 1791, 2011
31592011
Metallo-β-lactamases: the quiet before the storm?
TR Walsh, MA Toleman, L Poirel, P Nordmann
Clinical microbiology reviews 18 (2), 306-325, 2005
24092005
Multiplex PCR for detection of acquired carbapenemase genes
L Poirel, TR Walsh, V Cuvillier, P Nordmann
Diagnostic microbiology and infectious disease 70 (1), 119-123, 2011
21912011
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
LS Munoz-Price, L Poirel, RA Bonomo, MJ Schwaber, GL Daikos, ...
The Lancet infectious diseases 13 (9), 785-796, 2013
19732013
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
L Poirel, P Nordmann
Clinical Microbiology and Infection 12 (9), 826-836, 2006
15532006
Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes
L Poirel, A Jayol, P Nordmann
Clinical microbiology reviews 30 (2), 557-596, 2017
14922017
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
L Poirel, C Héritier, V Tolün, P Nordmann
Antimicrobial agents and chemotherapy 48 (1), 15-22, 2004
14242004
Carbapenem resistance in Enterobacteriaceae: here is the storm!
P Nordmann, L Dortet, L Poirel
Trends in molecular medicine 18 (5), 263-272, 2012
14192012
CTX-M: changing the face of ESBLs in Europe
DM Livermore, R Canton, M Gniadkowski, P Nordmann, GM Rossolini, ...
Journal of Antimicrobial Chemotherapy 59 (2), 165-174, 2007
13642007
Emerging carbapenemases in Gram-negative aerobes
P Nordmann, L Poirel
Clinical Microbiology and Infection 8 (6), 321-331, 2002
12122002
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
JDD Pitout, P Nordmann, KB Laupland, L Poirel
Journal of antimicrobial chemotherapy 56 (1), 52-59, 2005
11732005
OXA-48-like carbapenemases: the phantom menace
L Poirel, A Potron, P Nordmann
Journal of Antimicrobial Chemotherapy 67 (7), 1597-1606, 2012
11252012
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
PE Fournier, D Vallenet, V Barbe, S Audic, H Ogata, L Poirel, H Richet, ...
PLoS genetics 2 (1), e7, 2006
11112006
Rapid detection of carbapenemase-producing Enterobacteriaceae
P Nordmann, L Poirel, L Dortet
Emerging infectious diseases 18 (9), 1503, 2012
10252012
Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance
JDD Pitout, P Nordmann, L Poirel
Antimicrobial agents and chemotherapy 59 (10), 5873-5884, 2015
9852015
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15
TM Coque, Â Novais, A Carattoli, L Poirel, J Pitout, L Peixe, F Baquero, ...
Emerging infectious diseases 14 (2), 195, 2008
9822008
Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical …
L Poirel, T Naas, D Nicolas, L Collet, S Bellais, JD Cavallo, P Nordmann
Antimicrobial agents and chemotherapy 44 (4), 891-897, 2000
8942000
Diversity, epidemiology, and genetics of class D β-lactamases
L Poirel, T Naas, P Nordmann
Antimicrobial agents and chemotherapy 54 (1), 24-38, 2010
8862010
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
P Nordmann, L Poirel
Clinical Microbiology and Infection 20 (9), 821-830, 2014
8792014
Antimicrobial Resistance in Escherichia coli
L Poirel, JY Madec, A Lupo, AK Schink, N Kieffer, P Nordmann, ...
Microbiology spectrum 6 (4), 10.1128/microbiolspec. arba-0026-2017, 2018
8732018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20